Hossein A. Ghofrani, MD
University Hospital Giessen
Giessen, Germany

Session Chair
Future Therapy of Pulmonary Arterial Hypertension: Reversing Advanced Disease with Anti-proliferative Agents

Hossein A. Ghofrani received his medical degree from the Medical School at Giessen University in Germany. He is Associate Professor for Internal Medicine at University Hospital Giessen. He currently is Head of the Pulmonary Hypertension Division, Department of Internal Medicine, at Giessen. He also leads a collaborative group on Cardiopulmonary Vascular System research.

Dr. Ghofrani has participated in the therapeutic development of surfactant for the treatment of acute respiratory distress syndrome (ARDS); prostanoids, PDE inhibitors, combination therapies, and soluble guanylate cyclase activators and stimulators for pulmonary hypertension; endothelin antagonists for chronic lung disease and pulmonary hypertension; and tyrosine kinase inhibitors for pulmonary vascular diseases.

He has received four awards for investigations in pulmonary vascular science and is a reviewer for several medical scientific journals including the American Journal of Respiratory and Critical Care Medicine, Circulation, and Lancet.